Agena Bioscience AMP 2024 Workshop PGx
32:40
Agena Bioscience AMP 2024 Workshop PGx
19 сағат бұрын
Panel Talk: Standardizing Pharmacogenomics Laboratory Processes and Reporting
1:00:20
Panel Talk: Standardizing Pharmacogenomics Laboratory Processes and Reporting
9 ай бұрын
Advocating for DPYD Testing to Advance Patient Safety Based on Insights from Clinical Evidence
52:58
Advocating for DPYD Testing to Advance Patient Safety Based on Insights from Clinical Evidence
Жыл бұрын
Rethinking Solid Tumor Profiling: How Complementary Technologies Allow Better Treatment Decisions
38:46
Rethinking Solid Tumor Profiling: How Complementary Technologies Allow Better Treatment Decisions
Жыл бұрын
Webinar: PGx Testing Developments and Future Directions
1:00:41
Webinar: PGx Testing Developments and Future Directions
Жыл бұрын
Webinar: Unlocking Precision Medicine - Implementing a Novel PGx Prescribing Program
51:59
Webinar: Unlocking Precision Medicine - Implementing a Novel PGx Prescribing Program
Жыл бұрын
Webinar: PGx-Guided Pharmacotherapy: Recent Developments & Implementation in Clinical Practice
1:04:42
Webinar: PGx-Guided Pharmacotherapy: Recent Developments & Implementation in Clinical Practice
Жыл бұрын
Webinar: Performing Population-based Newborn Screening for Cystic Fibrosis in the State of Illinois
1:01:08
Webinar: Performing Population-based Newborn Screening for Cystic Fibrosis in the State of Illinois
Жыл бұрын
Webinar: Recent Developments in PGx - Predictive Biomarker Identification and Relevance
1:02:05
Webinar: Recent Developments in PGx - Predictive Biomarker Identification and Relevance
Жыл бұрын
Advancement of Pharmacogenomic (PGx) Testing: Development of Evidence-based Guidelines
36:05
Advancement of Pharmacogenomic (PGx) Testing: Development of Evidence-based Guidelines
2 жыл бұрын
Webinar: Authenticating Laboratory Results - Molecular Sample Tracking for NGS Laboratories
22:36
Webinar: Authenticating Laboratory Results - Molecular Sample Tracking for NGS Laboratories
3 жыл бұрын
Webinar: Detection of therapeutically targetable mutations in NSCLC
56:48
Webinar: Detection of therapeutically targetable mutations in NSCLC
3 жыл бұрын
Webinar: The Promise of Liquid Biopsy for Individualizing Cancer Care
1:00:10
Webinar: The Promise of Liquid Biopsy for Individualizing Cancer Care
3 жыл бұрын
Detection & Discrimination of SARS-CoV-2 Variants of Concern - An Alternative Approach to NGS
18:32
Detection & Discrimination of SARS-CoV-2 Variants of Concern - An Alternative Approach to NGS
3 жыл бұрын
Webinar: Responding to Emerging SARS CoV 2 Variants
58:29
Webinar: Responding to Emerging SARS CoV 2 Variants
3 жыл бұрын
Hybrid Alleles: Why It's Important to Detect Them & How Agena Does it Better
2:10
Hybrid Alleles: Why It's Important to Detect Them & How Agena Does it Better
3 жыл бұрын
Webinar: Responding to the COVID-19 Pandemic - Clinical Laboratories Perspectives
57:57
Webinar: Responding to the COVID-19 Pandemic - Clinical Laboratories Perspectives
4 жыл бұрын
Webinar: A Pharmacogenetic (PGx) Blindspot: The Prevalence and Impact of CYP2D6 Hybrid Alleles
1:09:40
Webinar: A Pharmacogenetic (PGx) Blindspot: The Prevalence and Impact of CYP2D6 Hybrid Alleles
4 жыл бұрын
Webinar: Going beyond EGFR: Evaluating technologies for molecular genetic testing in NSCLC
43:43
Webinar: Going beyond EGFR: Evaluating technologies for molecular genetic testing in NSCLC
4 жыл бұрын
Webinar: Evaluating Drug-Drug Interactions: Implications of Phenoconversions
56:51
Webinar: Evaluating Drug-Drug Interactions: Implications of Phenoconversions
4 жыл бұрын
MassARRAY® System by Agena Bioscience - 2020
7:08
MassARRAY® System by Agena Bioscience - 2020
4 жыл бұрын
Webinar: Targeted Detection of MET and NTRK Oncogenic Variants in Routine Molecular Analysis
57:57
Webinar: Targeted Detection of MET and NTRK Oncogenic Variants in Routine Molecular Analysis
5 жыл бұрын
AMP 2019 PGx Workshop: The Prevalence and Impact of CYP2D6 Hybrid Alleles
1:03:14
AMP 2019 PGx Workshop: The Prevalence and Impact of CYP2D6 Hybrid Alleles
5 жыл бұрын
Low Cost, High Sensitivity: The Advantages of MALDI-TOF for Liquid Biopsy and Solid Tumor Profiling
56:45
Low Cost, High Sensitivity: The Advantages of MALDI-TOF for Liquid Biopsy and Solid Tumor Profiling
5 жыл бұрын
Webinar: PGx Beyond Drug-Metabolizing Enzymes - A Multigene Approach to Predicting Drug Response
1:00:04
Webinar: PGx Beyond Drug-Metabolizing Enzymes - A Multigene Approach to Predicting Drug Response
5 жыл бұрын
Chinese Webinar: Application of DNA Methylation in Early Cancer Screening and Diagnosis
43:53
Chinese Webinar: Application of DNA Methylation in Early Cancer Screening and Diagnosis
5 жыл бұрын
Webinar: Hereditary Cancer Risk Assessment - Benefit vs. Cost in Precision Medicine
37:05
Webinar: Hereditary Cancer Risk Assessment - Benefit vs. Cost in Precision Medicine
5 жыл бұрын
Chinese Webinar: Clinical Applicability of Multi-site PGx Detection for Cardiovascular Diseases
37:38
Chinese Webinar: Clinical Applicability of Multi-site PGx Detection for Cardiovascular Diseases
5 жыл бұрын
Webinar: PGx Characterization of Challenging Samples: Management of Low-Quality DNA & Hybrid Alleles
49:56
Webinar: PGx Characterization of Challenging Samples: Management of Low-Quality DNA & Hybrid Alleles
5 жыл бұрын
Пікірлер
@PappuPappu-kf8ww
@PappuPappu-kf8ww Жыл бұрын
kzbin.info/www/bejne/bGanaHuQbrGBb9U